Short Interest in Bioxytran, Inc. (OTCMKTS:BIXT) Rises By 235.7%

Bioxytran, Inc. (OTCMKTS:BIXT) saw a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 38,600 shares, a growth of 235.7% from the July 15th total of 11,500 shares. Based on an average daily volume of 153,200 shares, the short-interest ratio is currently 0.3 days.

Bioxytran Stock Performance

Shares of OTCMKTS:BIXT remained flat at $0.11 on Monday. 20,000 shares of the stock were exchanged, compared to its average volume of 90,860. The company has a market capitalization of $19.49 million, a price-to-earnings ratio of -3.67 and a beta of -0.85. Bioxytran has a fifty-two week low of $0.07 and a fifty-two week high of $0.35. The stock’s fifty day simple moving average is $0.11 and its 200-day simple moving average is $0.11.

About Bioxytran

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.